Mechanisms governing the control of mRNA translation

被引：57

作者：

Livingstone, Mark ^{[1
,2
]}

Atas, Evrim ^{[3
,4
]}

Meller, Amit ^{[3
,4
]}

Sonenberg, Nahum ^{[1
,2
]}

机构：

[1] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada

[2] McGill Univ, McGill Canc Ctr, Montreal, PQ H3A 1A3, Canada

[3] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA

[4] Boston Univ, Dept Phys, Boston, MA 02215 USA

来源：

PHYSICAL BIOLOGY | 2010年 / 7卷 / 02期

关键词：

INITIATION-FACTOR; 4E; MAMMALIAN TARGET; MOTIF PHOSPHORYLATION; BINDING PARTNER; MTOR; RAPAMYCIN; PROTEIN; ACTIVATION; PATHWAY; CANCER;

D O I：

10.1088/1478-3975/7/2/021001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The translation of cellular mRNA to protein is a tightly controlled process often deregulated in diseases such as cancer. Furthering our understanding of mRNA structural elements and the intracellular proteins and signaling pathways that affect protein expression is crucial in the development of new therapies. In this review, we discuss the current state-of-the-art of detecting and determining the role of mRNA sequence elements in regulating the initiation of mRNA translation and the therapeutic strategies that exploit this knowledge to treat disease.

引用

页数：8

共 66 条

[1]

Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI [10.1517/14728222.12.2.209, 10.1517/14728222.12.2.209 ]

[2] Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells [J].

Avdulov, S ;

Li, S ;

Michalek, V ;

Burrichter, D ;

Peterson, M ;

Perlman, DM ;

Manivel, JC ;

Sonenberg, N ;

Yee, D ;

Bitterman, PB ;

Polunovsky, VA .

CANCER CELL, 2004, 5 (06) :553-563

[3] The 5' terminal oligopyrimidine-tract confers translational control on TOP mRNAs in a cell-type and sequence context-dependent manner [J].

Avni, D ;

Biberman, Y ;

Meyuhas, O .

NUCLEIC ACIDS RESEARCH, 1997, 25 (05) :995-1001

[4] Quantifying the benefits of translation regulation in the unfolded protein response [J].

Axelsen, JB ;

Sneppen, K .

PHYSICAL BIOLOGY, 2004, 1 (03) :159-165

[5] Inhibition of mammalian target of rapamycin signaling by 2-(Morpholin-1-yl) pyrimido[2,1-α]isoquinolin-4-one [J].

Ballou, Lisa M. ;

Selinger, Elzbieta S. ;

Choi, Jun Yong ;

Drueckhammer, Dale G. ;

Lin, Richard Z. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (33) :24463-24470

[6] Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation [J].

Beretta, L ;

Gingras, AC ;

Svitkin, YV ;

Hall, MN ;

Sonenberg, N .

EMBO JOURNAL, 1996, 15 (03) :658-664

[7] A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J].

BROWN, EJ ;

ALBERS, MW ;

SHIN, TB ;

ICHIKAWA, K ;

KEITH, CT ;

LANE, WS ;

SCHREIBER, SL .

NATURE, 1994, 369 (6483) :756-758

[8] TORgeting oncogene addiction for cancer therapy [J].

Choo, AY ;

Blenis, J .

CANCER CELL, 2006, 9 (02) :77-79

[9] CENTRAL DOGMA OF MOLECULAR BIOLOGY [J].

CRICK, F .

NATURE, 1970, 227 (5258) :561-&

[10] Regulation of poly(A)-binding protein through PABP-interacting proteins [J].

Derry, M. C. ;

Yanagiya, A. ;

Martineau, Y. ;

Sonenberg, N. .

COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 2006, 71 :537-543

← 1 2 3 4 5 6 7 →